Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy. (Q33630784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

N L Henry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Nguyen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

F Azzouz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

L Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Philips

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

D Cao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

T C Skaar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J M Rae

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A M Storniolo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

D A Flockhart

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

D F Hayes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

V Stearns

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

294-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605460

13 February 2020

exact match

0 references

cites work

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Bone mineral density changes during the menopause transition in a multiethnic cohort of women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Germline pharmacogenetics of tamoxifen response: have we learned enough?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Aromatase inhibitors and bone health in women with breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

The causes and treatment of bone loss associated with carcinoma of the breast

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Score tests for association between traits and haplotypes when linkage phase is ambiguous

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Estrogen receptor genotypes and haplotypes associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Multiple genetic loci for bone mineral density and fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816645

Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes

30 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605460

Sex steroids and bone density in premenopausal and perimenopausal women

21 January 2018

1 reference

12 December 2020

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

12 December 2020

Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction

1 reference

12 December 2020

Tamoxifen in the treatment of breast cancer

1 reference

12 December 2020

Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival

1 reference

12 December 2020

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

1 reference

12 December 2020

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17

1 reference

12 December 2020

Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants

1 reference

12 December 2020

Estrogen receptor genotypes and their association with the 10-year changes in bone mineral density and osteocalcin concentrations

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19953095%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference